A Phase 1/2 open-label multi-centre study to assess the safety, pharmacokinetics, and anti-tumour activity of GTAEXS617 in patients with advanced solid tumours

Principal Investigator

Dr Simon Lord

Contact us

Email: orh-tr.earlyphasenurses@nhs.net

IRAS number

1006825